136 related articles for article (PubMed ID: 38204196)
1. Innovative strategies for effective paclitaxel delivery: Recent developments and prospects.
Wileński S; Koper A; Śledzińska P; Bebyn M; Koper K
J Oncol Pharm Pract; 2024 Mar; 30(2):367-384. PubMed ID: 38204196
[TBL] [Abstract][Full Text] [Related]
2. Recent Developments and Anticancer Therapeutics of Paclitaxel: An Update.
Ahmed Khalil A; Rauf A; Alhumaydhi FA; Aljohani ASM; Javed MS; Khan MA; Khan IA; El-Esawi MA; Bawazeer S; Bouyahya A; Rebezov M; Shariati MA; Thiruvengadam M
Curr Pharm Des; 2022; 28(41):3363-3373. PubMed ID: 36330627
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. AIE luminogen labeled polymeric micelles for biological imaging and chemotherapy.
Liang N; Xu Y; Zhao W; Liu Z; Li G; Sun S
Colloids Surf B Biointerfaces; 2024 Mar; 235():113792. PubMed ID: 38340417
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel Drug Delivery Systems: Focus on Nanocrystals' Surface Modifications.
Haddad R; Alrabadi N; Altaani B; Li T
Polymers (Basel); 2022 Feb; 14(4):. PubMed ID: 35215570
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel Nano-Delivery Systems: A Comprehensive Review.
Ma P; Mumper RJ
J Nanomed Nanotechnol; 2013 Feb; 4(2):1000164. PubMed ID: 24163786
[TBL] [Abstract][Full Text] [Related]
7. Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.
Wang F; Porter M; Konstantopoulos A; Zhang P; Cui H
J Control Release; 2017 Dec; 267():100-118. PubMed ID: 28958854
[TBL] [Abstract][Full Text] [Related]
8. Oral delivery of paclitaxel by polymeric micelles: A comparison of different block length on uptake, permeability and oral bioavailability.
Sze LP; Li HY; Lai KLA; Chow SF; Li Q; KennethTo KW; Lam TNT; Lee WYT
Colloids Surf B Biointerfaces; 2019 Dec; 184():110554. PubMed ID: 31627103
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel drug delivery systems.
Zhang Z; Mei L; Feng SS
Expert Opin Drug Deliv; 2013 Mar; 10(3):325-40. PubMed ID: 23289542
[TBL] [Abstract][Full Text] [Related]
10. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.
Shi Y; van der Meel R; Theek B; Oude Blenke E; Pieters EH; Fens MH; Ehling J; Schiffelers RM; Storm G; van Nostrum CF; Lammers T; Hennink WE
ACS Nano; 2015; 9(4):3740-52. PubMed ID: 25831471
[TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles.
Dhanikula AB; Singh DR; Panchagnula R
Curr Drug Deliv; 2005 Jan; 2(1):35-44. PubMed ID: 16305406
[TBL] [Abstract][Full Text] [Related]
12. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
13. Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel.
Zhang X; Wu Y; Zhang M; Mao J; Wu Y; Zhang Y; Yao J; Xu C; Guo W; Yu B
Int J Nanomedicine; 2017; 12():8779-8799. PubMed ID: 29263668
[TBL] [Abstract][Full Text] [Related]
14. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
[TBL] [Abstract][Full Text] [Related]
15. Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization.
Lee SC; Huh KM; Lee J; Cho YW; Galinsky RE; Park K
Biomacromolecules; 2007 Jan; 8(1):202-8. PubMed ID: 17206808
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
17. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.
Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
Drug Deliv; 2012 May; 19(4):169-76. PubMed ID: 22506922
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel and its formulations.
Singla AK; Garg A; Aggarwal D
Int J Pharm; 2002 Mar; 235(1-2):179-92. PubMed ID: 11879753
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics.
Sarkar M; Wang Y; Ekpenyong O; Liang D; Xie H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1846. PubMed ID: 35979879
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Characterization of Spray-Dried Inhalable Powders Containing Polymeric Micelles for Pulmonary Delivery of Paclitaxel in Lung Cancer.
Rezazadeh M; Davatsaz Z; Emami J; Hasanzadeh F; Jahanian-Najafabadi A
J Pharm Pharm Sci; 2018; 21(1s):200s-214s. PubMed ID: 30321135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
